Ditchcarbon
  • Customers
  1. Organizations
  2. Sandoz
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated 10 days ago

Sandoz

Company website

Sandoz, a division of Novartis, is a global leader in the pharmaceutical industry, headquartered in Switzerland (CH). Founded in 1886, Sandoz has established itself as a pioneer in generic and biosimilar medicines, focusing on high-quality, affordable healthcare solutions. With a strong presence in Europe, North America, and emerging markets, the company is dedicated to improving patient access to essential medications. Sandoz's core offerings include a diverse range of generic pharmaceuticals, biosimilars, and over-the-counter products, distinguished by their rigorous quality standards and innovative approaches. The company has achieved significant milestones, including the launch of several groundbreaking biosimilars, solidifying its position as a trusted partner in the healthcare sector. With a commitment to sustainability and patient-centric solutions, Sandoz continues to shape the future of medicine.

DitchCarbon Score

How does Sandoz's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

71

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Sandoz's score of 71 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

84%

Let us know if this data was useful to you

Sandoz's reported carbon emissions

In 2024, Sandoz reported total carbon emissions of approximately 1,740,000,000 kg CO2e, with emissions distributed across various scopes: 82,100,000 kg CO2e (Scope 1), 157,600,000 kg CO2e (Scope 2), and 1,748,800,000 kg CO2e (Scope 3). The previous year, 2023, saw slightly higher emissions at about 2,052,000,000 kg CO2e, with Scope 1 emissions at 86,200,000 kg CO2e, Scope 2 at 122,300,000 kg CO2e, and Scope 3 at 2,051,700,000 kg CO2e. Sandoz has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 emissions to near zero by 2025. Additionally, the company plans to achieve a 30% reduction in both Scope 1 and Scope 2 emissions from a 2020 baseline by 2030. For Scope 3 emissions, which constitute the majority of their carbon footprint, Sandoz has not specified reduction targets but is actively working towards overall sustainability. The company is committed to reaching net zero emissions by 2050, reflecting its long-term dedication to climate action. These targets are part of Sandoz's broader strategy to align with industry standards and contribute to global climate goals. All emissions data and commitments are sourced directly from Sandoz Group AG, with no cascaded data from parent organizations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
75,620
00,000
00,000,000
00,000,000
Scope 2
158,430
000,000
000,000,000
000,000,000
Scope 3
-
-
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sandoz's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sandoz is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sandoz is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Genentech

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Concord Biotech

IN
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Bausch Health Cos

CA
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Hikma Pharmaceuticals

GB
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

MERCK Kommanditgesellschaft auf Aktien

DE
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.10
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy